Nuron Biotech, Pfizer deal

Nuron acquired Pfizer's HibTITER Haemophilus influenzae type b ( Hib) vaccine. Nuron will have rights to market the vaccine worldwide, except in four or five "non-strategic" countries. Pfizer gained the vaccine through its 2009 acquisition of Wyeth, which withdrew the vaccine from the market. Further terms were not disclosed. ...